Data on the use of antivirals to treat cytomegalovirus infection in infants are limited, with ganciclovir being the current first choice

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.5, 2010-05, pp. : 10-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ganciclovir: An Update of its Use in the Prevention of Cytomegalovirus Infection and Disease in Transplant Recipients

By McGavin J.K.   Goa K.L.  

Drugs, Vol. 61, Iss. 8, 2001-01 ,pp. : 1153-1183

Adis International

Access to resources Recommend Favorite

Ganciclovir: An Update of its Use in the Prevention of Cytomegalovirus Infection and Disease in Transplant Recipients

By Noble S.   Faulds D.  

Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. : 115-146

Adis International

Access to resources Recommend Favorite

Antivirals for Cytomegalovirus Infection in Neonates and Infants: Focus on Pharmacokinetics, Formulations, Dosing, and Adverse Events

By Marshall Beth C.   Koch William C.  

Pediatric Drugs, Vol. 11, Iss. 5, 2009-10 ,pp. : 309-321

Adis International

Access to resources Recommend Favorite

Ganciclovir/valganciclovir: Development of resistance in cytomegalovirus infection in a newborn: case report

By  

Reactions Weekly, Vol. 1, Iss. 1416, 2012-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Current or New Cytomegalovirus Antivirals and Novel Animal Model Strategies

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 4, 2010-09 ,pp. : 286-299

Bentham Science Publishers

Access to resources Recommend Favorite